NCT06227377
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06227377
Title QTX3034 in Patients With KRAS G12D Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Quanta Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Hematology/Oncology RECRUITING Los Angeles California 90095 United States Details
Sarah Cannon Research Institute (SCRI) RECRUITING Denver Colorado 80218 United States Details
Yale Cancer Center RECRUITING New Haven Connecticut 06511 United States Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
Montefiore Medical Center RECRUITING The Bronx New York 10461 United States Details
Duke University RECRUITING Durham North Carolina 27710 United States Details
Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
SCRI- Nashville RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson RECRUITING Houston Texas 77030 United States Details
START San Antonio, LLC RECRUITING San Antonio Texas 78229 United States Details
University of Utah, Huntsman Cancer Center RECRUITING Salt Lake City Utah 84112 United States Details
NEXT Oncology Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field